Literature DB >> 7911917

Effect of pregnancy on prognosis for young women with breast cancer.

V F Guinee1, H Olsson, T Möller, K R Hess, S H Taylor, T Fahey, J V Gladikov, J W van den Blink, F Bonichon, S Dische.   

Abstract

Breast cancer in women under 30 years old carries a poor prognosis, for reasons that have not been identified. This study aimed to identify prognostic factors in this age group. Special attention was paid to the history of pregnancy. The clinical presentation and course of breast cancer was documented for 407 women, aged 20-29 years, who registered between 1978 and 1988 at one of nine cancer centres. Eligible patients had histologically confirmed local or regional invasive breast carcinoma, and received part or all of their initial therapy at the participating hospital. For patients whose breast cancers were diagnosed during pregnancy, the risk of dying from breast cancer was significantly greater than that of women who had never been pregnant (relative risk 3.26 [95% CI 1.81-5.87], p = 0.0004). Adjustment for number of axillary nodes affected and tumour diameter reduced the relative risk only slightly (2.83 [1.24-6.45], p = 0.023). For each 1-year increment in the time between the latest previous pregnancy and breast cancer diagnosis, the risk of dying decreased by 15% (relative risk 0.85, p = 0.011). Thus concurrent or recent previous pregnancy adversely affects survival of breast cancer in young women. The size of the effect is such that it probably contributes substantially to the poor prognosis of breast cancer in this age group as a whole.

Entities:  

Mesh:

Year:  1994        PMID: 7911917     DOI: 10.1016/s0140-6736(94)93054-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Multiple births and breast cancer prognosis: a population based study.

Authors:  Lukman Thalib; Suhail A R Doi; Per Hall
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  Pregnancy and breast cancer.

Authors:  Ludger Barthelmes; Louise A Davidson; Christopher Gaffney; Christopher A Gateley
Journal:  BMJ       Date:  2005-06-11

3.  Axillary nodal involvement and parity in breast cancer patients.

Authors:  I S Fentiman; P Smith
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 4.  Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature.

Authors:  J Raphael; M E Trudeau; K Chan
Journal:  Curr Oncol       Date:  2015-03       Impact factor: 3.677

5.  Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study.

Authors:  Lilla Madaras; Kristóf Attila Kovács; Attila Marcell Szász; István Kenessey; Anna-Mária Tőkés; Borbála Székely; Zsuzsanna Baranyák; Orsolya Kiss; Magdolna Dank; Janina Kulka
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

6.  Pregnancy-associated breast cancer: an entity needing refinement of the definition.

Authors:  Virginia F Borges; Pepper J Schedin
Journal:  Cancer       Date:  2011-11-15       Impact factor: 6.860

7.  Impact of Time Since Last Childbirth on Survival of Women with Premenopausal and Postmenopausal Breast Cancers.

Authors:  Nanthini Balakrishnan; Soo-Hwang Teo; Siamala Sinnadurai; Nanthini Thevi Bhoo Pathy; Mee-Hoong See; Nur Aishah Taib; Cheng-Har Yip; Nirmala Bhoo Pathy
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

Review 8.  Breast cancer diagnosis during pregnancy.

Authors:  Jennifer K Litton; Richard L Theriault; Ana M Gonzalez-Angulo
Journal:  Womens Health (Lond)       Date:  2009-05

9.  Pregnancy and breast cancer: a population-based study.

Authors:  W Reed; E Hannisdal; E Skovlund; S Thoresen; P Lilleng; J M Nesland
Journal:  Virchows Arch       Date:  2003-05-20       Impact factor: 4.064

Review 10.  Pregnancy and breast cancer: when they collide.

Authors:  Traci R Lyons; Pepper J Schedin; Virginia F Borges
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-21       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.